WMS Partners’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
WMS Partners's DGX Position: Q2 2022 in Review
WMS Partners sold out of Quest Diagnostics (DGX) in Q2 2022, closing a stake of 1,555 shares — an estimated $213K sold.
WMS Partners first reported a position in DGX in Q4 2014 and held it in 22 quarters. The position peaked at $304K in Q4 2021. 850 funds tracked by Wall St. Rank hold DGX as of Q2 2022.
- WMS Partners reported no remaining Quest Diagnostics position as of Q2 2022 after selling out during the quarter.
- WMS Partners sold 1,555 Quest Diagnostics shares in Q2 2022, an estimated $213K.
- WMS Partners first reported a position in Quest Diagnostics in Q4 2014 and held it in 22 quarters.
- WMS Partners's Quest Diagnostics position peaked at $304K in Q4 2021.
- 850 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.
Based on WMS Partners's 13F filing for Q2 2022, filed 5 Aug 2022.